Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Orvosi Hetilap|July 22, 2006
[Surveys of the consumption of nutritional antioxidants in inflammatory bowel diseases]Olga Dörnyei, Agota Kovács, Edit Székely, et al.Orvosi Hetilap|September 16, 2004
[Redox homeostasis in inflammatory bowel diseases]Anna Blázovics, Klára Szentmihályi, László Prónai, et al.Journal of Clinical Psychology in Medical Settings|December 24, 2008
Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorderGabriella Seres, Zoltán Kovács, Agota Kovács, et al.Immunogenetics|June 18, 2003
Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel diseaseAgnes Vatay, László Bene, Agota Kovács, et al.Orvosi Hetilap|August 24, 2004
[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]László Lakatos, Péter László Lakatos, Claudia Willheim-Polli, et al.Digestive Diseases and Sciences|June 26, 2003
High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitisLászló Bene, George Füst, Béla Fekete, et al.Digestive Diseases and Sciences|July 27, 2002
Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel diseaseLaszló Bene, George Füst, Zoltán Huszti, et al.Orvosi Hetilap|November 8, 2006
[Haptoglobin polymorphism in patients with inflammatory bowel diseases]Mária Papp, Péter László Lakatos, , et al.Orvosi Hetilap|February 6, 2010
[Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease]László Lakatos, Zsófia Czeglédi, Gyula Dávid, et al.Pageof 1